Aibotics, Inc. (AIBT)
0.0029
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Aibotics Enterprise Value : 3.152M for Oct. 7, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 3.152M |
| October 06, 2026 | 3.152M |
| October 05, 2026 | 2.358M |
| October 02, 2026 | 2.647M |
| October 01, 2026 | 2.285M |
| September 30, 2026 | 2.166M |
| September 29, 2026 | 2.285M |
| September 28, 2026 | 1.780M |
| September 25, 2026 | 1.780M |
| September 24, 2026 | 1.707M |
| September 23, 2026 | 1.924M |
| September 22, 2026 | 1.780M |
| September 21, 2026 | 1.924M |
| September 18, 2026 | 1.852M |
| September 17, 2026 | 1.996M |
| September 16, 2026 | 2.069M |
| September 15, 2026 | 1.924M |
| September 14, 2026 | 1.780M |
| September 11, 2026 | 1.744M |
| September 10, 2026 | 1.635M |
| September 09, 2026 | 1.563M |
| September 08, 2026 | 1.346M |
| September 04, 2026 | 1.346M |
| September 03, 2026 | 1.346M |
| September 02, 2026 | 1.346M |
| Date | Value |
|---|---|
| September 01, 2026 | 1.31M |
| August 31, 2026 | 1.274M |
| August 28, 2026 | 1.274M |
| August 27, 2026 | 1.346M |
| August 26, 2026 | 1.418M |
| August 25, 2026 | 1.418M |
| August 24, 2026 | 1.346M |
| August 21, 2026 | 1.418M |
| August 20, 2026 | 1.346M |
| August 19, 2026 | 1.346M |
| August 18, 2026 | 1.346M |
| August 17, 2026 | 1.274M |
| August 14, 2026 | 1.346M |
| August 13, 2026 | 1.346M |
| August 12, 2026 | 1.317M |
| August 11, 2026 | 1.346M |
| August 10, 2026 | 1.371M |
| August 07, 2026 | 1.379M |
| August 06, 2026 | 1.371M |
| August 05, 2026 | 1.418M |
| August 04, 2026 | 1.491M |
| August 03, 2026 | 1.491M |
| July 31, 2026 | 1.346M |
| July 30, 2026 | 1.346M |
| July 29, 2026 | 1.346M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CS Diagnostics Corp. | -- |
| GeneDx Holdings Corp. | 2.077B |
| Ayujoy Herbals Ltd. | -- |
| Arrowhead Pharmaceuticals, Inc. | 8.452B |
| Oncolytics Biotech, Inc. | 70.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.537M |
| Total Expenses (Quarterly) | 0.537M |
| EPS Diluted (Quarterly) | -0.0008 |
| Earnings Yield | -189.7% |
| Normalized Earnings Yield | -179.31 |